Locally Advanced Malignant Neoplasm Terminated Phase 3 Trials for Capecitabine (DB01101)

IndicationStatusPhase
DBCOND0047902 (Locally Advanced Malignant Neoplasm)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01836432Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic CancerTreatment